Urology

Resumen de las presentaciones seleccionadas de la cumbre OM Pharma/Vifor Pharma URO-VAXOM® celebrada en Buenos Aires (Argentina) los días 26 y 27…

Urolithiasis constitutes a worldwide health problem with a frequency of up to 15% in the general population.

During the last 15 years, minimally invasive surgery has been introduced gradually in surgical treatment for prostate cancer (CaP).

Most clinical practice guidelines (CPGs) assume that general practitioners (GPs) can manage non- complicated benign prostatic hyperplasia (BPH)-related…

Prostatitis is a commonly seen clinical entity in daily urological practice.

Summary of the Enuresis Lecture, held at the 25th Annual ESPU Congress, Innsbruck, Austria, on 9th May 2014

Bladder cancer (BC) is the ninth most commonly diagnosed malignant tumour in the world, with an incidence of about 356,000 and a mortality of about 145,000 per year in both non-muscle-invasive and muscle-invasive BC.

Although urolithiasis is considered as a rare entity in children, it is an important health problem in the world, especially in endemic areas.